Dr. Paul Gagne

Paul J. Gagne, MD, is a practicing vascular surgeon with The Vascular Care Group (TVCG), Darien, CT. His current focus is on severe chronic venous hypertension and deep and superficial venous disease. Dr. Gagne is the President of Vascular Breakthroughs, a clinical research company conducting clinical trials and research in the vascular intervention space. He is also the Chief of Clinical Operations for Mangrove Management Partners, focused on the efficient and patient-focused operation of outpatient Vascular Centers (TVCG) providing clinic, vascular lab, and interventional (OBL) services at 9 centers in New England.

Dr. Gagne has a broad research background in basic science and clinical vascular interventions. He is broadly published and has been the principal investigator in dozens of clinical trials. Since 2007, his research focus has been on severe chronic venous hypertension and venous disease. He is currently also focused on improving the work environment for vascular surgeons to promote innovation, professional satisfaction, and efficient and “cutting-edge” patient care for the benefit of surgeons and their patients.

He is a graduate of the College of the Holy Cross and the New York University School of Medicine. He trained as a general surgeon at New York University and in Vascular Surgery at the University of Arkansas for Medical Sciences, Little Rock. He is a Board-Certified Vascular Surgeon.

Dr. Gagne served for 8 years as a general and vascular surgeon in the US Navy before returning to the Vascular Surgery faculty of New York University Medical Center in 1999. While at NYU, he was awarded an NIH research grant for the study of angiogenesis in critical limb ischemia. He was also the principal investigator for several clinical trials evaluating new clinical devices. He started Vascular Breakthroughs in 2003 and The Vascular Care Group (TVCG), Darien, in 2021.